Longevity Peptides: Anti-Aging Options and the Research Behind Them
Medically reviewed by Medical Advisory Board Last reviewed 2026-09-05
Epithalon, GHK-Cu, thymalin, and the evidence for peptide-based longevity interventions — including the short peptide bioregulators
Longevity peptides target cellular aging mechanisms — telomere protection, oxidative stress, immune regulation, and hormonal optimization. This guide covers the evidence for epithalon, GHK-Cu, and growth hormone peptides as anti-aging interventions.
Anti-aging peptides are distinct from performance or recovery peptides: they target the fundamental mechanisms of aging rather than immediate physiological optimization. The most studied are epithalon (telomerase activation), GHK-Cu (tissue repair and gene expression), thymalin (immune system regulation), and growth hormone secretagogues (addressing somatopause).
Epithalon, thymalin, and pinealon fall into a specific sub-category sometimes called "bioregulator peptides" or "short peptide bioregulators." These ultra-short peptides, made up of 2 to 4 amino acids, were developed at the St. Petersburg Institute of Bioregulation and Gerontology. They are intended to regulate gene expression in a specific organ system, the pineal gland for epithalon and pinealon, and the thymus for thymalin, rather than act as a broad hormone replacement. They are sold as research compounds, not FDA-approved drugs, and the same evidence caveats below apply to them.
Partner · Opt Health
Want peptides prescribed and monitored properly?
If you're considering peptide therapy, the difference between a clinical program and a gray-market vial is supervision. Opt Health prescribes peptides through licensed physicians with baseline labs and follow-up testing.
See Opt Health's peptide program →The evidence base for longevity peptides is still largely preclinical: extensive animal studies, some compelling in vitro data, and decades of Russian institutional research that lacks the RCT validation standard of Western medicine. That doesn't mean the compounds are ineffective, but it does mean that applying these findings to human aging requires careful interpretation.
Top Longevity Peptides and Evidence
| Peptide | Target Mechanism | Evidence Level | Human Data? |
|---|---|---|---|
| Epithalon | Telomerase activation, telomere extension | Animal studies + in vitro | Limited (Russian observational) |
| GHK-Cu | Gene expression (700+ genes), collagen synthesis | In vitro + some animal | Cosmetic RCTs (skin) |
| Thymalin | Immune system rejuvenation (thymic function) | Animal studies + Russian clinical | Russian retrospective |
| Sermorelin / CJC-1295 | GH/IGF-1 somatopause reversal | Animal + human RCTs (sermorelin) | Yes (FDA-approved) |
| BPC-157 | Gut-brain-tissue repair axis | Extensive animal | Limited |
| Pinealon | Neuroprotection, circadian regulation | Animal studies | Russian limited |
GHK-Cu (Copper Peptide)
GHK-Cu (glycyl-L-histidyl-L-lysine complexed with copper) is a naturally occurring tripeptide found in human plasma, urine, and saliva. Its concentration declines dramatically with age (from ~200 ng/mL at age 20 to ~80 ng/mL at age 60).
GHK-Cu is remarkable for its broad gene expression effects — research by Loren Pickart and Arul Bhanu Maan has shown GHK activates over 700 human genes involved in: tissue repair and remodeling, antioxidant defense, anti-inflammatory signaling, neurological function, and cancer suppression genes. This broad transcriptomic effect makes it unlike any other anti-aging intervention.
GHK-Cu is available topically (widely used in skincare for skin collagen synthesis) and injectable/subcutaneous forms. Evidence for systemic aging effects is largely in vitro and animal models.
The Organ-Specific Bioregulator Series
The bioregulator line extends well past the pineal and thymus compounds, into a product for almost every organ, and the published evidence does not extend with it. Searches for a thyroid, kidney or liver bioregulator all land on the same commercial category. These are animal tissue extracts named for the organ they came from, sold in capsules. Knowing which ones carry published human work saves money on the ones that do not.
A 2013 clinical review from Khavinson's group at the St. Petersburg Institute of Bioregulation and Gerontology names seven preparations, and those seven are the whole published human record. The review covers Thymalin, Thymogen, Vilon, Epithalamin, Prostatilen, Cortexin and Retinalamin.
| Organ targeted | Preparation | Published human work? |
|---|---|---|
| Thymus | Thymalin, Thymogen, Vilon | Yes, Russian clinical studies |
| Pineal gland | Epithalamin, epithalon | Yes, Russian clinical studies |
| Prostate | Prostatilen | Yes, Russian clinical studies |
| Brain cortex | Cortexin | Yes, Russian clinical studies |
| Retina | Retinalamin | Yes, Russian clinical studies |
| Thyroid, kidney, liver, heart, lung, pancreas, ovary, bladder, cartilage, blood vessels | Sold under brand names by organ | Not in that review; no Western trial found |
Those organ-named capsules are the most searched of the series and the only ones with no published human study behind them. For the compound with the most human data in the series, see our page on thymalin.
None of these has FDA approval in the United States. Thymalin was not among the seven peptides the FDA's Pharmacy Compounding Advisory Committee reviewed in July 2026, so no pharmacy has a lawful path to compound it. Buying any of them means buying a research chemical, so treat the organ name on the label as marketing rather than as a claim anyone has tested.
Addressing Somatopause: The GH Approach to Anti-Aging
Somatopause — the progressive decline in GH secretion of approximately 15% per decade after age 30 — is one of the most well-characterized biological aging processes. By age 60, most adults have <20% of their peak GH secretion.
GH and IGF-1 govern muscle mass, bone density, body fat distribution, skin collagen, cognitive function, and immune regulation. Restoring GH to youthful ranges through GHRH/GHRP peptides (sermorelin, CJC-1295/ipamorelin) is the most clinically validated approach to hormonal anti-aging.
Frequently Asked Questions
What are longevity peptides?
Longevity peptides are amino acid chains that target fundamental aging mechanisms — telomere protection (epithalon), gene expression and tissue repair (GHK-Cu), immune rejuvenation (thymalin), or hormonal aging (GH secretagogues). Unlike performance peptides that optimize a single system, longevity peptides aim at root causes of biological aging.
Do anti-aging peptides work?
The evidence varies by compound. Growth hormone secretagogues (sermorelin, CJC-1295/ipamorelin) have the strongest human evidence — multiple clinical trials showing body composition improvements, IGF-1 elevation, and metabolic benefits. Epithalon has compelling animal and in vitro telomere data but limited human RCTs. GHK-Cu has strong mechanistic data and cosmetic RCTs for skin. None have been proven to extend human lifespan in controlled trials.
What is the best peptide for anti-aging?
For the most evidence-backed approach: sermorelin or CJC-1295 + ipamorelin to address somatopause (GH decline) — this has both clinical trial support and decades of off-label use. For cellular longevity targeting: epithalon (telomere mechanism) combined with GHK-Cu (broad gene expression support). Many longevity practitioners combine a GH peptide with epithalon in annual or semi-annual courses.
What are bioregulator peptides?
Bioregulator peptides (also called short peptide bioregulators) are ultra-short peptides — typically 2-4 amino acids — developed at the St. Petersburg Institute of Bioregulation and Gerontology to regulate gene expression in a specific organ system rather than act as a broad hormone. Epithalon (pineal/telomerase-linked), thymalin (thymus/immune function), and pinealon (neuroprotection) are the most-discussed examples, and are the same compounds covered in the table above. Like other longevity peptides, they are sold as research compounds, not FDA-approved drugs, and the human evidence is thinner than the animal and Russian-institutional research base.
Topic updates
Get the weekly peptide roundup
Peptide therapy, GLP-1s, growth hormone peptides, healing peptides, safety notes, and comparison guides.
Want peptide therapy handled by a physician who works from your labs? See how Opt Health does it →
Check Where You Stand
Take our free health assessment to understand your metabolic, hormonal, and recovery risk factors — and get personalized recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results
Related Reading
-
Peptide Therapy: What It Is, How It Works, and Who It's For
What peptide therapy is, how it works, and how to access it.
-
BPC-157: Healing Peptide Benefits, Dosage, and Safety
BPC-157 benefits, dosage, research, and tissue repair mechanism.
-
Ipamorelin: Growth Hormone Peptide Benefits, Dosage & Results
Ipamorelin for growth hormone release, body composition, and recovery.
See more related reading
-
Sermorelin: Anti-aging Growth Hormone Therapy Guide
Sermorelin therapy for HGH stimulation, aging, and body composition.
-
CJC-1295: GHRH Analog Benefits, Dosage, and Stacking Guide
CJC-1295 dosage, benefits, and how to stack with ipamorelin.
-
TB-500 (Thymosin Beta-4): Tissue Repair Peptide Guide
TB-500 for injury repair, inflammation, and tissue regeneration.
-
Epithalon: the Longevity Peptide — Research, Benefits & Dosage
Epithalon's telomere and longevity research — what the evidence shows.
-
Thymalin: the Thymus Peptide, Its Trial Evidence and Safety
Thymalin: what the 2003 mortality study and the 2021 COVID-19 trial actually showed.